Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (18918)	2/18/1999 7:29:00 PM
From: Zebra 365	Read Replies (2) \| Respond to of 23519

The last good thing I heard about MUSE was from Pfizer <<<PS If anyone is currently aware of any marketing currently being done by Vivus to promote MUSE please let me know.>>> Seriously, as a PCP, the last thing I got that mentioned MUSE as a treatment was some foundation "sponsored by a grant from Pfizer". Now that PFE has nullified the competition, they can just do "general awareness" ads that there is effective treatment for ED. Since the relabeling of Viagra, they cannot do a 30-second spot because that would spend most of the time on the side-effects and risks. If they don't mention the drug by name, no cautions are necessary. I polled 11 docs last night, multiple specialties, no urologists, half were PCP's. Only one, another internist, had even heard of MUSE, and he has never written an Rx for it. All have heard of Viagra. And all were aware of risks in CV disease patients. The only ones who had not written Viagra Rx's were orthopedist, pediatrician and Ob-gyn. Just an observation. Still a long-suffering long here because of the product, not the company. Zebra